On the other hand, both NIS mRNA and iodide uptake were elevated in human follicular thyroid carcinoma cell lines, suggesting that RA treatment could be used to up-regulate NIS expression and thus iodide uptake in tumor cells to be targeted differentially by radioiodide treatment (56). This evidence concerns the gene SLC5A5 and thyroid gland follicular carcinoma.